secwatch.observer — SEC 8-K summary
======================================

Issuer:     KALA BIO, Inc. (KALA)
CIK:        0001479419
Form:       8-K
Filed at:   2026-02-05T23:59:59+00:00
Accession:  0001829126-26-000995
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

KALA BIO CEO & CFO David Lazar resigns; director Avi Minkowitz appointed same day
--------------------------------------------------------------------------------

- David Lazar resigned as CEO and CFO effective Feb 2, 2026, remains on board.
- Board appointed director Avi Minkowitz as new CEO and CFO effective same date.
- Minkowitz previously VP at Parkit Enterprise and analyst at Leonite Capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479419/000182912626000995/0001829126-26-000995-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479419/000182912626000995/kalabio_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-26-000995

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer